Transvaginal Mesh Lawyers at Bernstein Liebhard LLP Note New Order in New Jersey C.R. Bard Litigation Concerning Handling of Explants and Tissue Samples

The Firm is currently representing hundreds of women who allegedly suffered serious transvaginal mesh complications due to products manufactured by C.R. Bard and other companies.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Free Case Review
This Order will ensure that medical evidence important to plaintiffs’ claims is properly preserved.

New York, New York (PRWEB) June 17, 2013

Lawsuits involving alleged transvaginal mesh complications associated with products manufactured by C.R. Bard, Inc. continue to move forward in a Multicounty Litigation now underway in New Jersey’s Atlantic County Superior Court, Bernstein Liebhard LLP reports. On May 31st, the Court issued a new Consent Order that set forth protocols for the preservation and testing of explanted devices and tissue samples for the litigation’s bellwether cases. Court documents indicate that the first of those bellwether cases will begin going to trial on September 23, 2013. (In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)

“This Order will ensure that medical evidence important to plaintiffs’ claims is properly preserved. We are pleased to see that the C.R. Bard transvaginal mesh lawsuits pending in New Jersey are moving forward, and look forward to the start of the proceeding’s first trials,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm’s transvaginal mesh lawyers continue to offer free legal consultations to women who allegedly suffered serious complications following implantation of devices manufactured by C.R. Bard, Inc., as well as American Medical Systems, Inc., Ethicon, Inc. and Boston Scientific Corp. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving as Co-Liaison Counsel in the C.R. Bard litigation underway in New Jersey.

Transvaginal Mesh Complications
In July 2011, the U.S. Food & Drug Administration (FDA) revealed that it had received more than 3,800 reports of serious complications involving transvaginal mesh products between 2005 and the end of 2010. The agency also changed its position regarding the frequency of such injuries in pelvic prolapse repair, declaring it no longer considered these complications to be rare.*

While no vaginal mesh recall was ordered by the agency at that time, court records show that thousands of women who were allegedly harmed by these devices began filing lawsuits in courts around the country. According to court filings in New Jersey, some 550 transvaginal mesh complication claims are pending against C.R. Bard in Atlantic County Superior Court. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is also serving as Co-Liaison Counsel in a second litigation underway in Atlantic County for claims involving Ethicon mesh products. He was also a member of the Plaintiff’s trial team in the litigation’s first Ethicon trial, which ended in an $11 million judgment in favor of a woman injured by the Gynecare Prolift device. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10)

Mr. Grand also serves on the Plaintiffs’ Steering Committees in several transvaginal litigations pending in the U.S. District Court, Southern District of West Virginia: In re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2325; In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation - MDL No. 2326; In re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2187; and In re: Ethicon, Inc. Pelvic Repair Systems Products Liability Litigation - MDL No. 2327. The first federal trial of a transvaginal mesh lawsuit is scheduled to begin on July 8th in the C.R. Bard multidistrict litigation, according to court records.

Women who have allegedly suffered serious transvaginal mesh complications may be entitled to compensation for their medical bills, pain and suffering, and other injuries. A wealth of information regarding vaginal mesh lawsuits can be found at Bernstein Liebhard LLP's website. To learn more, please call the Firm today, at 800-511-5092.

*fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm079028.htm

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.thevaginalmeshrecall.com/